Search

LetibotulinumtoxinA

[A249920] It was subsequently approved by the FDA in 1992 for use in aesthetic procedures and has since become one of the most popular cosmetic procedures worldwide. … [A249920] LetibotulinumtoxinA is a type A botulinum neurotoxin produced from fermentation of _Clostridium botulinum_ strain CBFC26.

Corticosterone

An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. … (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)

Indoprofen

Following reports of adverse reactions including reports of carcinogenicity in animal studies it was withdrawn from the market worldwide.

Nemolizumab

[A264254] By binding to IL-31RA, nemolizumab blocks the IL-31 signalling cascades that lead to inflammation. … [A264274] It was later approved by the FDA on August 13, 2024, for the treatment of prurigo nodularis.[L51169]

2-(aminomethyl)phenol

2-(aminomethyl)phenol is under investigation in clinical trial NCT03556319 (2-HOBA: Multiple Dosing Study in Older Adults).

VIT-100

VIT-100 was developed by ItherX Pharmaceuticals of San Diego. … It is believed that similar effects would be seen in cells isolated from hypertrophic scars.

Chromous sulfate

Butalbital

Butalbital, or 5-allyl-5-isobutylbarbituric acid, is a derivative of barbituric acid which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. … It is a short-to-intermediate acting member of barbiturates that exhibit muscle-relaxing and anti-anxiety properties that produce central nervous system (CNS) depression that ranges from mild sedation

Imolamine

It is developed under the brand name Coremax by Novartis consumer health SA.

Monopotassium phosphate

It can be used in fertilizer mixtures to reduce escape of ammonia by keeping pH low.